✦ LIBER ✦

2162 The optimal dose of radiation in Hodgkin's disease: Is 30 Gy adequate?

✍ Scribed by Nancy Price Mendenhall; Lori Lewis Rodrigue; Giselle J. Moore; Rodney R. Million

Book ID: 108435894
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 132 KB
Volume: 39
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(97)80929-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What is the optimal treatment volume in

What is the optimal treatment volume in Hodgkin's disease patients undergoing high-dose chemotherapy and adjuvant radiation therapy?

✍ Arno J. Mundt; Philip P. Connell; David B. Mansur 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

To determine the optimal treatment volume in Hodgkin's disease patients undergoing high-dose chemotherapy (HDCT) and radiation therapy (RT), failure sites were reviewed in 56 patients. Twenty-one (38%) received involved-field RT (IFRT) before or after HDCT encompassing sites of prior disease. Failur

Radiation doses following intensive chem

Radiation doses following intensive chemotherapy in the treatment of hodgkin's disease

✍ Leonard R. Prosnitz 📂 Article 📅 1976 🏛 Elsevier Science 🌐 English ⚖ 206 KB

460 oral Comparison of 30 Gy versus 20 G

460 oral Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's disease: interim results of the German Hodgkin's Lymphoma Study Group (GHSG) trial hd10

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 117 KB

The Dose of Elective Neck Irradiation as

The Dose of Elective Neck Irradiation as 46 Gy Is Feasible in Nasopharyngeal Carcinoma Treated by Intensity Modulated Radiation Therapy

✍ Hung, T.; Lin, C.; Chang, T. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 76 KB

High-dose therapy in patients with Hodgk

High-dose therapy in patients with Hodgkin’s disease: the use of selected CD34+ cells is as safe as unmanipulated peripheral blood progenitor cells

✍ Blystad, A K; Holte, H; Kvaløy, S; Smeland, E; Delabie, J; Kvalheim, G 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 144 KB

S1079 CYP2C19 Genotype Is a Useful Marke

S1079 CYP2C19 Genotype Is a Useful Marker of Optimal Dose of a Proton Pump Inhibitor in the Maintenance Therapy of Symptomatic Gastroesophageal Reflux Diseases

✍ Takahisa Furuta; Mitsushige Sugimoto; Chise Kodaira; Masafumi Nishino; Mihoko Ya 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 177 KB